Your browser doesn't support javascript.
loading
Grb2 inhibition: a new potential targeted therapy for myeloid malignancies?
Thomas, Xavier; Paubelle, Etienne.
Affiliation
  • Thomas X; Department of Hematology, Lyon-Sud Hospital, 69495 Pierre Bénite, France. Electronic address: xavier.thomas@chu-lyon.fr.
  • Paubelle E; Department of Hematology, Lyon-Sud Hospital, 69495 Pierre Bénite, France.
Lancet Haematol ; 5(4): e128-e129, 2018 04.
Article in En | MEDLINE | ID: mdl-29550385
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / GRB2 Adaptor Protein / Molecular Targeted Therapy Limits: Humans Language: En Journal: Lancet Haematol Year: 2018 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / GRB2 Adaptor Protein / Molecular Targeted Therapy Limits: Humans Language: En Journal: Lancet Haematol Year: 2018 Document type: Article Country of publication: United kingdom